Diligence memo · auto-generated · as of July 2, 2026
Intersect ENT, Inc.
Intersect ENT, Inc. looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
Intersect ENT, Inc. operates in Other Health Care, based in MENLO PARK.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Intersect ENT, Inc. has raised $86M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Series B (a $15M–$40M round).
Largest single filing: $31M on 2010-10-28.
Most recent recorded round closed around 2013-02-15.
Valuation (modeled)modeled
Provath models Intersect ENT, Inc. at approximately $462M (range $49M–$1.8B). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 1.04× the median modeled value of Series B Other Health Care companies in 2013–2015 (85 peers) — value vs value, same stage and era. Within the normal band (104% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 9 months.
Last raise 13.4 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 1.1× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 95% of Other Health Care peers (5376 compared).
Modeled value ranks above 93% of those peers.
Closest niche peers: Drynachan, Llc, Vistria SHC Holdings, LLC, Ebh Holding Company, Inc., Orthopediatrics Corp, Assurerx Health, Inc.
Peoplefiled
10 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.